Taconic Biosciences, Inc., a global leader in genetically engineered rodent models (GEMs) and humanized immune system (HIS) mouse models, announces the acquisition of TransCure bioServices SAS, a leading provider of preclinical research services utilizing HIS mouse models. This acquisition enables Taconic to offer a unified global platform delivering seamless end-to-end solutions for their customers – providing humanized models, precise cohort generation, and in vivo studies. “This acquisition establishes a fully integrated translational research engine giving researchers a more predictive, efficient, and reliable alternative than fragmented multi-vendor workflows,” said Mike Garrett, CEO of Taconic Biosciences.
Read the full article: Taconic Biosciences Acquires TransCure bioServices, Building a Comprehensive Global Platform for Humanized Mouse Translational Research //
Source: https://www.businesswire.com/news/home/20260120265917/en/Taconic-Biosciences-Acquires-TransCure-bioServices-Building-a-Comprehensive-Global-Platform-for-Humanized-Mouse-Translational-Research